What is OHCFF?
, a healthcare technology company, focuses on developing artificial intelligence health diagnostic solutions designed to differentiate between bacterial and viral infections at point-of-care facilities.
OHCFF · Verdict
Moderate reward · elevated risk
OHCFF's standout is volatility; cash flow and profitability weigh on the picture.
Based on 88% data coverage
OHCFF · Verdict
Top decile vs peers
Weak vs peers
-2399% return on equity
Current ratio 0.82
Earnings +83.1% CAGR
Model-based scoring. For information only — not financial advice.
, a healthcare technology company, focuses on developing artificial intelligence health diagnostic solutions designed to differentiate between bacterial and viral infections at point-of-care facilities. AI, a technology platform comprising a software operating as a medical device to automatically diagnose group A streptococcus infections. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 9.95M.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.